Biotech-Invest SRL
Biotech-Invest reported total assets of €2.21m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Mar 2026).
By total assets for 2025, Biotech-Invest ranks among the 500 largest of the 6,141 companies in its sector (NACE 7330) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Biotech-Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +20 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biotech-Invest's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 30 Mar 2026
- Year ended 30 Sep 2024filed on 28 Apr 2025
- Year ended 30 Sep 2023filed on 08 Apr 2024
- Year ended 30 Sep 2022filed on 04 Apr 2023
- Year ended 30 Sep 2021filed on 07 Apr 2022
Biotech-Invest's financial analysis
- Solvency79.0%sector median: 56.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biotech-Invest
Biotech-Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0476.881.001
- VAT number
- BE0476881001
- Peppol
- Registered · 0208:0476881001 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Feb 2002
- Registered office
- 9921 Lievegem
- Latest accounts
- 2025 · filed on 30 Mar 2026
- Activity
- Public relations and communication activities (NACE 73300)
Biotech-Invest (SRL) has been based in Lievegem since 2002, active in: public relations and communication activities. For 2025, it reports a net profit of 203,964 € and equity of €1.75m; its revenue is not published. Its solvency stands at 79.0%, above the median of its sector (56.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biotech-Invest
Companies in the same business, of comparable size and area, outside its group.
- Bracino Public relations and communication activities Oudenaarde · balance sheet €2.15m
- Heemconsult Public relations and communication activities Staden · balance sheet €2.03m
- Soete Invest Public relations and communication activities Anzegem · balance sheet €1.45m
- Belides Public relations and communication activities Ixelles · balance sheet €2.06m
- Ntrinsic Consulting Public relations and communication activities Brussels · balance sheet €2.40m
- JPRG Public relations and communication activities Bruges · balance sheet €2.70m
- Sharing Insights Public relations and communication activities Aalst · balance sheet €1.20m
- Chil Projects Public relations and communication activities Kaprijke · balance sheet €2.80m
Frequently asked questions about Biotech-Invest
What is the revenue of Biotech-Invest?
Biotech-Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biotech-Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0476881001 for Biotech-Invest, if the company is VAT-registered. Its company number (CBE) is 0476.881.001.
Where is the registered office of Biotech-Invest?
According to the CBE register, the registered office of Biotech-Invest is in 9921 Lievegem.
What is the equity of Biotech-Invest?
At the close of the 2025 financial year, the equity of Biotech-Invest amounts to 1,747,533 €, a solvency of 79.0% of total assets.
Who manages Biotech-Invest?
The register lists 2 active mandates at Biotech-Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Biotech-Invest within its sector?
By total assets for 2025, Biotech-Invest ranks among the 500 largest of the 6,141 companies in its sector (NACE 7330) in Belgium that filed accounts for that financial year.
The full file of Biotech-Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →